Latest ESPR reports update at 2024-05-07: 2024-Q1 ∙ 2023-Q1
  1. Home
  2. Stock quotes
  3. Esperion Therapeutics
  4. Financial Ratios
  5. EV/EBITDA Ratio
Esperion Therapeutics logo
Esperion Therapeutics ESPR
$ 2.16 -5.68%
mail-toReport an Error

Esperion Therapeutics EV/EBITDA Ratio 2011-2024 | ESPR

Annual EV/EBITDA Ratio Esperion Therapeutics

2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
-2.15 -5.97 -14.2 -5.73 -9.96 -2.82 -5.11 -18.6 -3.17 - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
-2.15 -18.6 -7.52